Corpus Intelligence IC Memo — MADERA COMMUNITY HOSPITAL 2026-04-26 15:56 UTC
IC Memo — MADERA COMMUNITY HOSPITAL
Investment Committee Memorandum | CA | 106 beds | Grade C | EBITDA uplift $7.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MADERA COMMUNITY HOSPITAL

CCN 050568 | MADERA, CA | 106 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MADERA COMMUNITY HOSPITAL is a 106-bed community hospital in MADERA, CA with $95.8M in net patient revenue and a -21.2% operating margin. The hospital serves a payer mix of 22.6% Medicare, 0.0% Medicaid, and 77.4% commercial.

Thesis: Undervalued. Our ML models identify $7.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -21.2% to -13.8% (+736bps).

Net Revenue HCRIS$95.8M
Current EBITDA COMPUTED$-20.3M
Operating Margin COMPUTED-21.2%
Occupancy HCRIS51.1%
Revenue / Bed COMPUTED$903K
Net-to-Gross HCRIS40.9%
Distress Probability MLnan%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
171
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -21.2% places it below the state median. Among 171 size-comparable peers (53-212 beds), the median margin is -4.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (53-212), prioritizing same-state peers. 171 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MADERA COMMUNITY HOSPITAL (Target)CA106$95.8M-21.2%
CHILDRENS HOSP & RES CNTR OAKLCA155$687.9M-7.1%
NORTHBAY HOSPITAL GROUPCA204$676.6M-8.2%
CONTRA COSTA REGIONAL MEDICAL CA124$595.0M-29.2%
KFH - VALLEJOCA184$531.7M0.3%
RANCHO LOS AMIGOS NATL.REHAB.CCA83$512.6M41.9%
DOMINICAN HOSPITALCA202$499.0M5.0%
CMH OF SAN BUENAVENTURACA170$498.5M-7.6%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.0M+210bp18mo
Cost to Collect4.5%2.5%$1.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.2M+122bp9mo
Clean Claim Rate88.0%96.0%$61K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.0M
Cost to Collect
$1.9M
Denial Rate Reduction
$1.9M
A/R Days Reduction
$1.2M
Clean Claim Rate
$61K
Total EBITDA Uplift$7.0M
Current EBITDA$-20.3M
+ RCM Uplift+$7.0M
Pro Forma EBITDA$-13.2M
Current Margin-21.2%
Pro Forma Margin-13.8%
WC Released (1x)$3.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-31.2M$-63.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-31.2M$-79.8M0.00x-100.0%
Bull Case9.0x11.0x$-28.1M$-66.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-28.1M$-81.0M0.00x-100.0%
Bear Case11.0x10.0x$-34.3M$-88.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-34.3M$-108.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 171 hospitals with 53-212 beds
  • Same-state prioritization (n=172)
  • Comp margins: P25=-20.3% / P50=-4.6% / P75=4.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.